Lazard Asset Management’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $116K | Buy |
+2,664
| New | +$116K | ﹤0.01% | 1840 |
|
|
2024
Q3 | – | Sell |
-2,856
| Closed | -$84K | – | 2372 |
|
|
2024
Q2 | $84K | Buy |
+2,856
| New | +$84K | ﹤0.01% | 1803 |
|
|
2022
Q1 | – | Sell |
-1,238
| Closed | -$78K | – | 2440 |
|
|
2021
Q4 | $78K | Buy |
+1,238
| New | +$78K | ﹤0.01% | 1535 |
|
|
2021
Q3 | – | Sell |
-1,512
| Closed | -$73K | – | 2226 |
|
|
2021
Q2 | $73K | Buy |
+1,512
| New | +$73K | ﹤0.01% | 1440 |
|